Progyny, Inc.

NASDAQ:PGNY

Medical - Healthcare Information Services

Healthcare
$36.16 -0.19%

-$0.05 today

Market cap
$2.66B
Beta
1.04
P/E (TTM)
31.4
EPS (TTM)
$0.84
52W Low $16.10High $28.75

Volume 0.88M

Average 1.49M

PGNY EPS (Diluted)

Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.

Progyny, Inc.NASDAQ: PGNY

EPS (Diluted) · Q2 FY2026 · quarter ended Jun 2026

EPS (Diluted) growth accelerates

Q2 FY2026 EPS (Diluted) of $0.34 rose 78.9% year over year, ahead of the +55.9% change in trailing-twelve-month EPS (Diluted). Sequentially, it rose 17.2% from the prior quarter. Over 3 fiscal years it compounded at +29.4% a year.

Context

  • EPS (Diluted) increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether EPS (Diluted) reaches the consensus estimate from 6 analysts of $1.32 (+102.6%) for the fiscal year ending Dec 2026, a step up from the +14.0% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$0.34+17.2% QoQ
Last fiscal yearDec 2025
$0.65+14.0% YoY
LTMJun 2026
$0.92+55.9% YoY
EPS (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+78.9%+108.7%+29.7 pp
1 year+14.0%+102.6%+88.6 pp
3-year CAGR+29.4%+41.7%+12.3 pp
5-year CAGR+24.4%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Diluted) history

USD · from the income statement

Latest · FY2025
0.65 USD
Year-over-year change
+14.0%
4-year CAGR
-0.4%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Diluted) vs competitors

How PGNY compares with its peers on the latest reported figures

  • PGNY's LTM Jun 2026 EPS (Diluted) of $0.92 is the 2nd highest of the 3 companies compared; the peer median is $1.33.
  • Its year-over-year change of +55.9% is the lowest of 3, against a peer median of +75.7%.
PGNY Competitors Peer median
EPS (Diluted) for PGNY and competitors
Company Period LTM YoY 3-year CAGR
HQYHealthEquity, Inc.LTM Jul 2026$2.77 +67.4%—
PGNYProgyny, Inc.LTM Jun 2026$0.92 +55.9%+29.4%
OMDAOmada HealthLTM Mar 2026-$0.11 +83.9%—
Peer median (excluding PGNY) $1.33+75.7%—

Competitors are the stored peer set for PGNY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue500.62M786.91M1.09B1.17B1.29B
Cost of Revenue388.49M619.59M849.8M913.86M984.18M
Gross Profit112.14M167.33M238.8M253.36M304.48M
Gross Margin22.4%21.3%21.9%21.7%23.6%
Research & Development00000
Selling, General & Admin79.8M143.98M176.62M185.91M219.21M
Operating Expenses79.8M143.98M176.62M185.91M219.21M
Depreciation & Amortization1.3M1.6M2.28M3.18M4.95M
EBITDA33.74M26.04M72.97M86.38M100.38M
EBITDA Margin6.7%3.3%6.7%7.4%7.8%
Operating Income32.34M23.34M62.18M67.46M85.28M
Operating Margin6.5%3.0%5.7%5.8%6.6%
Interest Income461K814K8.51M15.75M10.16M
Interest Expense00000
Other Income / Expenses95K1.1M8.51M15.75M10.16M
Income Before Tax32.44M24.44M70.69M83.2M95.43M
Pre-Tax Margin6.5%3.1%6.5%7.1%7.4%
Income Tax Expense(33.33M)(5.92M)8.65M28.87M36.91M
Net Income65.77M30.36M62.04M54.34M58.52M
Net Margin13.1%3.9%5.7%4.7%4.5%
EPS (Basic)0.740.330.650.590.68
EPS (Diluted)0.660.300.620.570.65
Weighted Avg Shares89.11M92.2M95.02M91.48M85.23M
Weighted Avg Shares (Diluted)100.36M99.96M100.67M95.45M89.46M

Progyny, Inc.

NASDAQ:PGNY

Intrinsic Alpha fair value

Locked

Current Price

$36.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.